Gene · 7086
Papers3,154
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,154
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mapping Conformational Changes in the Saliva Proteome Potentially Associated with Oral Cancer Aggressiveness. | J Proteome Res | 2024 | 38785273 | PubTator, text mining | PubMed |
| Biochemical, Bioinformatic, and Structural Comparisons of Transketolases and Position of Human Transketolase in the Enzyme Evolution. | Biochemistry | 2024 | 38767928 | PubTator, text mining | PubMed |
Incomplete immunization uptake and associated factors among children aged 12-23 months in sub-Saharan African countries; multilevel analysis evidenced from latest demography and health survey data, 2023. | Ital J Pediatr | 2024 | 38735946 | PubTator, text mining | PubMed |
| Race explains substantial variance in whole blood thiamine diphosphate concentrations. | Nutr Res | 2024 | 38696890 | PubTator, text mining | PubMed |
| Optimization of Quantum Nuclei Positions with the Adaptive Nuclear-Electronic Orbital Approach. | J Phys Chem A | 2024 | 38619054 | PubTator, text mining | PubMed |
| Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity. | Cell Metab | 2024 | 38547864 | PubTator, text mining | PubMed |
| Regulating TKT activity inhibits proliferation of human acute lymphoblastic leukemia cells. | Am J Cancer Res | 2024 | 38455402 | PubTator, text mining | PubMed |
| Lycorine inhibits migration and proliferation of hepatocellular carcinoma cells by reducing transketonase expression. | J Cancer | 2024 | 38434975 | PubTator, text mining | PubMed |
| Transketolase drives the development of aortic dissection by impairing mitochondrial bioenergetics. | Acta Physiol (Oxf) | 2024 | 38380737 | PubTator, text mining | PubMed |
| Laccase-based catalytic microreactor for BPA biotransformation. | Heliyon | 2024 | 38298720 | PubTator, text mining | PubMed |
| Salivary proteomic profile of response to different resistance training protocols: A case report. | Cell Biochem Funct | 2024 | 38269522 | PubTator, text mining | PubMed |
| The Phylogeny and Metabolic Potentials of a Lignocellulosic Material-Degrading Aliiglaciecola Bacterium Isolated from Intertidal Seawater in East China Sea. | Microorganisms | 2024 | 38257972 | PubTator, text mining | PubMed |
| Posttranslational Acylations of the Rat Brain Transketolase Discriminate the Enzyme Responses to Inhibitors of ThDP-Dependent Enzymes or Thiamine Transport. | Int J Mol Sci | 2024 | 38255994 | PubTator, text mining | PubMed |
| Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection. | Cancers (Basel) | 2024 | 38254762 | PubTator, text mining | PubMed |
| The Multifaceted Roles of NRF2 in Cancer: Friend or Foe? | Antioxidants (Basel) | 2024 | 38247494 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals overactive inflammation and dysregulated metabolism in severe community-acquired pneumonia patients. | Respir Res | 2024 | 38243232 | PubTator, text mining | PubMed |
| LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer. | Sci Rep | 2024 | 38233470 | PubTator, text mining | PubMed |
| Small Warriors of Nature: Novel Red Emissive Chlorophyllin Carbon Dots Harnessing Fenton-Fueled Ferroptosis for In Vitro and In Vivo Cancer Treatment. | Small | 2024 | 38230862 | PubTator, text mining | PubMed |
| Exploring the multifaceted role of NRF2 in brain physiology and cancer: A comprehensive review. | Neurooncol Adv | 2024 | 38221979 | PubTator, text mining | PubMed |
| TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma. | Oncogene | 2024 | 38216672 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7086/papers?page=8